EGCG and Quinine Sulfate Vaginal Suppository for papillomavirus infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 May 2026: Trial registered, NCT07572396

The trials

NCT07572396: Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

State
Under way
Phase
Phase 2
People
45 planned
Started
30 Apr 2026
Primary completion
27 Dec 2026
Arms
Dysplasix™ Intravaginal Suppositories
Results
None posted
  1. 7 May 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.